Publications by authors named "Ronald Schmidt"

Claim this Profile
S
Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
Guilherme S Accorsi, Luiza L Paiva, Ronald Schmidt, Marcelo Vieira, Ricardo Reis

J Minim Invasive Gynecol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Omics" data integration and functional analyses link Enoyl-CoA hydratase, short chain 1 to drug refractory dilated cardiomyopathy.
Nzali V Campbell, David A Weitzenkamp, Ian L Campbell, Ronald F Schmidt, Chindo Hicks

BMC Med Genomics· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in Unnecessary Clinical Laboratory Testing Through Utilization Management at a US Government Veterans Affairs Hospital.
Raymond L Konger, Paul Ndekwe, Genea Jones, Ronald P Schmidt, Marty Trey

Am J Clin Pathol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue.
Ulrich Werner, Marcus Korn, Ronald Schmidt, Thomas M Wendrich, Norbert Tennagels

Arch Physiol Biochem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of antimicrobial action of sodium metasilicate against Salmonella enterica serovar Typhimurium.
Chander Shekhar Sharma, Sally K Williams, Keith R Schneider, Ronald H Schmidt, Gary E Rodrick

Foodborne Pathog Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC-MS/MS of large molecules in a regulated bioanalytical environment - which acceptance criteria to apply?
Magnus Knutsson, Ronald Schmidt, Philip Timmerman

Bioanalysis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentrations of insulin glargine and its metabolites during long-term insulin therapy in type 2 diabetic patients and comparison of effects of insulin glargine, its metabolites, IGF-I, and human insulin on insulin and igf-I receptor signaling.
Aimee J Varewijck, Hannele Yki-Järvinen, Ronald Schmidt, Norbert Tennagels, Joseph A M J L Janssen

Diabetes· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes.
Paola Lucidi, Francesca Porcellati, Paolo Rossetti, Paola Candeloro, Anna Marinelli Andreoli, Ronald Schmidt

Diabetes Care· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exposure to insulin glargine and its metabolites M1 and M2 after subcutaneous injection of therapeutic and supratherapeutic doses of glargine in subjects with type 1 diabetes.
Geremia B Bolli, Annke D Hahn, Ronald Schmidt, Tanja Eisenblaetter, Raphael Dahmen

Diabetes Care· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial effects of sodium metasilicate against Listeria monocytogenes.
Chander Shekhar Sharma, Sally K Williams, Keith R Schneider, Ronald H Schmidt, Gary E Rodrick

Foodborne Pathog Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition.
Jeanine Pignatelli, David A Tumbarello, Ronald P Schmidt, Christopher E Turner

J Cell Biol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reshaping the healthcare delivery network.
Ronald Schmidt, Gene Altus

Healthc Financ Manage· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin D(2) sustains the pyrogenic effect of prostaglandin E(2).
Wei Gao, Achim Schmidtko, Ruirui Lu, Christian Brenneis, Carlo Angioni, Ronald Schmidt

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis.
Susanne Schiffmann, Jessica Sandner, Ronald Schmidt, Kerstin Birod, Ivonne Wobst, Helmut Schmidt

J Lipid Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib inhibits 5-lipoxygenase.
Thorsten J Maier, Lars Tausch, Michael Hoernig, Ovidiu Coste, Ronald Schmidt

Biochem Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dimethylcelecoxib inhibits prostaglandin E2 production.
Ivonne Wobst, Susanne Schiffmann, Kerstin Birod, Thorsten J Maier, Ronald Schmidt

Biochem Pharmacol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.
Norbert Degousee, Shafie Fazel, Denis Angoulvant, Eva Stefanski, Sven-Christian Pawelzik, Ronald Schmidt

Circulation· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice.
Christian Brenneis, Ovidiu Coste, Ronald Schmidt, Carlo Angioni, Laura Popp

J Cell Mol Med· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
Carolin Daniel, Nico A Sartory, Nadine Zahn, Ronald Schmidt, Gerd Geisslinger

Mol Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum.
Curtiss B Cook, Janna C Castro, Ronald E Schmidt, Susanne M Gauthier, Michael D Whitaker

J Hosp Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE-/- mice.
Julia Metzner, Laura Popp, Claudiu Marian, Ronald Schmidt, Christine Manderscheid

J Mol Med (Berl)· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors.
Rufina Schuligoi, Ronald Schmidt, Gerd Geisslinger, Manfred Kollroser, Bernhard A Peskar

Biochem Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convenient medical clinics reshaping the healthcare landscape.
Ronald Schmidt, Ray Kolar, Carrie Fairfield

Healthc Financ Manage· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of aggregation on the electrical conductivity of spin-coated polymer/carbon nanotube composite films.
Ronald H Schmidt, Ian A Kinloch, Andrew N Burgess, Alan H Windle

Langmuir· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes care in the hospital: is there clinical inertia?
Laura A D Knecht, Susanne M Gauthier, Janna C Castro, Ronald E Schmidt, Michael D Whitaker

J Hosp Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis